OS Therapies appointed Dr. Craig Eagle to its board of directors, effective June 1, 2026, following the resignation of Karim Galzahr.
| IndividualKarim GalzahrDr. Craig Eagle | RoleDirector (departing)Director (appointed); Chief Medical Advisor (advisory role) | Type of ChangeResignedAppointed | Effective DateJune 1, 2026June 1, 2026 | ReasonResignation not due to any disagreement with the Company on operations, policies or practicesTo fill vacancy created by resignation | Replacement InfoDr. Craig Eagle appointed to fill vacancyFilled vacancy created by Karim Galzahr's resignation | Background DetailsNot disclosedCurrent Chief Medical Officer of Guardant Health since May 2021; former VP Medical Affairs Oncology at Genentech (2019–May 2021); ~10 years in senior oncology roles at Pfizer; MD from University of New South Wales; internal medicine training at Royal North Shore Hospital | Board/Committee Role ChangesNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.